Abstract
Type 2 diabetes (T2D) is a chronic metabolic disorder marked by insulin resistance and relative insulin deficiency, affecting over 422 million people globally and projected to increase, making it a major public health concern. This condition is associated with severe complications such as retinopathy, nephropathy, cardiovascular diseases, and neuropathy, highlighting the need for a deeper understanding of its mechanisms to develop more effective prevention and treatment strategies. Transcriptomic analysis, particularly through RNA-seq, has provided valuable insights into the gene expression patterns in T2D, highlighting pathways involved in insulin signaling, metabolic regulation, and inflammation. This approach, including single-cell RNA sequencing, helps overcome the challenges of immune cell population heterogeneity, enabling the identification of distinct cell types and their specific roles in T2D progression. In this paper, we present a dataset of single-cell and bulk RNA sequencing results comparing expression patterns in blood cells between diabetes and healthy samples and describe some preliminary analysis of the dataset, highlighting differences in both gene expression and cell type composition and putting them in the context of existing research of T2D.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Ministry of Science and Higher Education of the Russian Federation (project Multicenter research bioresource collection Human Reproductive Health contract No. 075-15-2021-1058 from 28 September 2021).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Ethics Committee of D.O. Ott Institute of Obstetrics, Gynecology, and Reproductology (protocol #130 from 16 July 2020)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
(Tonyan Z.N. ziravard{at}yandex.ru, Nasykhova Y.A. yulnasa{at}gmail.com, Barbitoff Y.A. barbitoff{at}bk.ru, Renev I.N. iaroslav.renev.98{at}gmail.com, Danilova M.M. elenamariamassa{at}gmail.com, Mikhailova A.A. anamikhajlova{at}gmail.com, Glavnova O.B. o.glavnova{at}mail.ru, Selkov S.A. selkovsa{at}mail.ru, Chepanov S.V. chepanovsv{at}gmail.com, Glotov A.S. anglotov{at}mail.ru)
(Golovkin N.V. golovkin1983{at}yandex.ru, Vlasova M.E. vlasovaritafi{at}gmail.com)
Data Availability
Single cell RNA sequencing raw data and CellRanger processing results are deposited in Gene Expression Omnibus under accession GSE280401. Bulk RNA sequencing raw data, counts and TPMs are deposited under GSE280402. Note that subject enumeration is continuous in these accessions and subject 2 and 4 are included in both types of experiments.
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280401
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280402
Data Availability Statement
Single cell RNA sequencing raw data and CellRanger processing results are deposited in Gene Expression Omnibus under accession GSE280401. Bulk RNA sequencing raw data, counts and TPMs are deposited under GSE280402. Note that subject enumeration is continuous in these accessions and subject 2 and 4 are included in both types of experiments.
